This webinar offers an overview of the benefits early-phase, health-economic modelling can provide, at a stage when the outcome of the product development program is still largely unknown. Early-Phase Modelling balances between accuracy and manageability, and represents an easy to grasp, conceptual overview of your product and its potentials regarding reimbursement.
Proud to bring inspirational speakers from across the globe.
Senior Manager, Health Economics & Outcomes Research
Åse Björstad is a licensed pharmacist, and holds a PhD in Medicine with special emphasis on leukocyte biology from the University of Gothenburg, Sweden. Following her doctoral thesis, she held a position as a lecturer at the faculty of Pharmacy and Pharmaceutical Sciences at the University of Umeå. In 2010, she was recruited to Nordic Health Economics (now PharmaLex) and has since then gained 9 years of experience from hands-on work and project management within health economics and real-world evidence studies.